Navigation Links
Unomedical Issues Worldwide Recall of Certain Manual Pulmonary Resuscitators
Date:10/6/2009

not need to be returned.

The MPR is a single-patient use device used by healthcare professionals. It is intended for patients requiring total or intermittent ventilatory support.

Unomedical notified the U.S. Food & Drug Administration (FDA) of its decision to voluntarily recall the product on October 1, 2009.

Customers with questions are urged to contact Unomedical at 1-800-634-6003. Any adverse reactions experienced with the use of this product, and/or quality problems can also be reported to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by Fax at 1-800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch.

About Unomedical

Unomedical is a provider of medical devices with global operations. For more information, please visit www.unomedical.com.

    Media Contacts:

    Peter Duda or Hallie Bozzi
    Weber Shandwick
    212-445-8287
    unomedical@webershandwick.com
    9am - 6pm (EST)

    Customer Contacts:

    Americas
    Raymond Mendoza
    1-800-634-6003
    8:00am - 5:30pm Mon-Thurs, 8:00am - 1:00pm Fri (CST)

    Europe
    Betina Simonsen
    +45 4810 3036
    8:00am - 4pm Mon-Fri (CET)

    Asia
    Winnie Hui
    + 65 6593 1568
    9:00am - 5:00pm Mon-Fri (SGT)

    Russia
    Michael Martikhin
    +7 49 57487884
    8:30am - 5pm Mon-Fri (MSK)

SOURCE Unomedical Inc.


'/>"/>
SOURCE Unomedical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Issues Complete Response Letter for Carisbamate
2. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
3. Society of Gynecologic Oncologists Issues White Paper on HPV Vaccines Impact on Cervical Cancer Prevention
4. Pennsylvania Agriculture Department Issues Quarantine for Allegheny County Horse Stable
5. FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents
6. Avon Protection Systems Issues Correction/Clarification on ST53 SCBA System
7. Pharmos Issues Business Update on Dextofisopam Trial and Financing
8. U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
9. FDA Issues a Complete Response Letter for Lillys Olanzapine LAI for Treatment of Schizophrenia in Adults
10. Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients
11. MatTeks EpiDerm In Vitro Tissues Headed for Validation in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4q7gwz/india_pharma ) ... Outlook 2015: Accelerating growth to the next level - ... to their offering. Domestic sales improved ... caused by the market,s reaction to the new drug ... to be healthy, as the momentum continues and improving ...
(Date:3/5/2015)... 2015 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... developing products that address unmet medical needs in the ... its President and Chief Executive Officer, Christopher J. ... the 27 th Annual ROTH Conference in ... 10, 2015 at 1:00 PM Pacific Daylight Time (PDT).  ...
(Date:3/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/5sqnn3/global_rising ) has ... Outlook 2015" report to their offering. ... after with fresh vigor as new targets , approaches ... to bring a paradigm change in the way diseases ... cell therapy/Regenerative Medicine space. The number of ...
Breaking Medicine Technology:India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3Global Pharma Rising Stars Outlook 2015 2
... renarrowing less likely, with no increase in mortality on ... ... have,become widely used for the treatment of stable coronary artery disease,many ... (MI), citing conflicting data about the safety and,effectiveness of drug-eluting stents ...
... to heart ... muscle, ... clot that break loose during percutaneous coronary intervention,(PCI) has failed to show ... coronary syndromes, a condition that,encompasses unstable angina and a type of heart ...
Cached Medicine Technology:Large Study Gives Nod to Drug-Eluting Stents in Heart Attack 2Large Study Gives Nod to Drug-Eluting Stents in Heart Attack 3Filter Fails to Improve PCI Outcomes in Acute Coronary Syndromes 2Filter Fails to Improve PCI Outcomes in Acute Coronary Syndromes 3
(Date:3/5/2015)... NC (PRWEB) March 05, 2015 ... Physician Assistants’ (AAPA) review of Clearstream, LLC ... determined that Clearstream’s MediDefense line of products—led by ... the AAPA’s Affinity Partner Program. , The AAPA—which ... assistants across all medical and surgical specialties in ...
(Date:3/5/2015)... Diego, CA (PRWEB) March 05, 2015 ... it is now running on 100% pollution-free electricity ... Arcadia Power. , As an Arcadia Power ... Protection Agency’s (EPA) Green Power Partnership requirements, joining ... Starbucks that also purchase clean energy. Earth Source ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 The ... week released a special issue devoted ... field of PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated ... an autoimmune reaction triggered by infections such as ... result in inflammation of the child's brain. This ...
(Date:3/5/2015)... BROOK, Ill. (PRWEB) March 05, 2015 Think ... may be even tougher to get them to brush their ... than 1,300 parents released today by Delta Dental(1) in conjunction ... of parents (45 percent) say getting kids to brush their ... their kids to do. That’s slightly higher than getting children ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Wimbledon ... which provides vascular, echocardiogram and NCV testing, ... as the Chief Medical Officer. Dr. Artel will be ... development of the WimbledonMED program and the continued growth ... passionate about working with Wimbledon Health Partners as a ...
Breaking Medicine News(10 mins):Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4Health News:Earth Source Organics to Run on Clean Energy from Arcadia Power 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 3Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 3Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 2Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 3
... is among the first to describe the prevalence of ... a researcher from the University of California, San Diego ... drug use and accompanying high-risk behavior could lead to ... findings suggest that interventions to reduce high-risk behaviors among ...
... ARBOR, Mich.--- A camper who chases a grizzly but won,t ... to the boss. New research shows that not all risk ... risky and non-risky behaviors. , The survey also shows that ... of Michigan research refutes the standard theories of risk that ...
... specialists at Thomas Jefferson University are examining an innovative ... the procedure, known as Genial Bone Advancement Trephine (GBAT), ... to the tongue is moved forward, to pull the ... the airway space. It is considered an option for ...
... regardless of HDL level, study found , MONDAY, Aug. 27 ... cholesterol do not protect against increased blood pressure ... , The study of more than 21,000 men, ages 20-29 ... than the younger men to blood pressure increases associated with ...
... OAK BROOK, Ill. Using magnetic resonance (MR) images ... related to disease progression and disability in patients with ... the August issue of Radiology. , Based on ... sclerosis more accurately and identify patients at risk for ...
... , UCLA scientists have found the first evidence that ... degeneration yet not increase the risk for estrogen-induced cancers of ... mice infected with the animal equivalent of multiple sclerosis. ... have many choices for anti-inflammatory drugs to help prevent flare-ups ...
Cached Medicine News:Health News:High-risk behaviors could lead to HIV epidemic in Afghanistan 2Health News:High-risk behaviors could lead to HIV epidemic in Afghanistan 3Health News:Not all risk is created equal 2Health News:Jefferson specialists studying innovative surgery for effectively treating sleep apnea 2Health News:New MRI finding sheds light on multiple sclerosis disease progressio 2
For the quantitative in vitro determination of Transferrin in human serum...
For the quantitative in vitro determination of Transferrin in Serum...
Determination of the Thrombin Time by STA Analyzers. Freeze-dried human thrombin (1.5NIH units/mL) with calcium....
Quantitative determination of Fibrinogen (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Medicine Products: